SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.61 CNY | +0.16% |
|
+1.12% | -13.63% |
| 2023 | Sinobioway Biomedicine's Unit to Relocate | MT |
| 2023 | Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shandong Sinobioway Biomedicine Co Ltd, formerly Zibo Wanchang Science & Technology Co Ltd, is a China-based company principally engaged in the manufacturing of pharmaceuticals. The Company is engaged in the business of interferon, nerve growth factor, biopharmaceutical contract research organization (CRO)/pharmaceutical contract development and manufacturing enterprise (CDMO), vaccines and pharmaceutical intermediates. The Company's main products include anferon, encyclopedia, Corona Virus Disease2019 vaccine and others. The Company distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -13.63% | 1.15B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- 002581 Stock
- News Shandong Sinobioway Biomedicine Co., Ltd.
- Sinobioway Biomedicine Taps Builders for Planned Industrial Park
